Abstract | OBJECTIVE: DESIGN: A randomized, double-blind study (ClinicalTrials.gov identifier: NCT00982722). METHODS: The study included 150 pHPT patients randomized, 6 weeks after PTX, to daily treatment with either cholecalciferol 1600 IU and calcium carbonate 1000 mg (D+) or calcium carbonate alone (D-). HRQoL was estimated with SF-36 before and after PTX and after 12 months of study medication. RESULTS: Three-quarters (77%) of the pHPT patients had vitamin D insufficiency, defined as 25OHD <50 nmol/l. The pHPT patients scored lower than a reference population in all domains of SF-36. A total of 135 patients completed the entire study period. Improvements in nearly all domains were registered at the follow-up 6 weeks after PTX. At the end of the study medication period, the D+ group had a significantly higher median serum (s-) 25OHD concentration (76 (65; 93) (lower; upper interquartile ranges) vs 48 (40; 62) nmol/l, P<0.001) and a lower plasma (p-) parathyroid hormone concentration (40 (34; 52) vs 49 (38; 66) ng/l, P=0.01) than the D- group. The improvements in HRQoL remained unchanged at the follow-up 1 year after PTX. Postoperative vitamin D supplementation had no obvious effect on HRQoL. CONCLUSION: PTX resulted in significant improvements in HRQoL. Despite a high prevalence of vitamin D insufficiency, 1 year of postoperative vitamin D supplementation had no obvious beneficial effect on HRQoL.
|
Authors | Viveca Åberg, Sophie Norenstedt, Jan Zedenius, Maria Sääf, Jörgen Nordenström, Ylva Pernow, Inga-Lena Nilsson |
Journal | European journal of endocrinology
(Eur J Endocrinol)
Vol. 172
Issue 2
Pg. 181-7
(Feb 2015)
ISSN: 1479-683X [Electronic] England |
PMID | 25414430
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © 2015 The authors. |
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Cohort Studies
- Dietary Supplements
- Double-Blind Method
- Female
- Health Surveys
(methods)
- Humans
- Hyperparathyroidism, Primary
(diagnosis, drug therapy, surgery)
- Male
- Middle Aged
- Postoperative Care
(methods)
- Quality of Life
- Treatment Outcome
- Vitamin D
(administration & dosage)
|